Mathews Journal of Pharmaceutical Science (MJPS; ISSN: 2474-753X) is international scholarly journal that publishes original research pertaining to diverse pharmaceutical science related topics, such as pro-drug development, drug delivery, drug action, clinical research, drug stability, dosage form design, rational use of pharmacotherapy, metabolic disposition of bioactive agents, targeted drug delivery, regulatory affairs, pharmaceutical biotechnology, pharmacokinetics, pharmacodynamics, ADME, pharmaceutical analysis, bioequivalence and bioavailability, molecular pharmaceutics, biopharmaceutics, microencapsulation, and protein-peptide chemistry with specific focus on pharmaceutical technology.
Special impetus is placed on papers related to drug safety and dealing with topics, such as pharmacoepidemiology, pharmacovigilance, risk management, benefit-risk assessment, and medication error prevention.
This leading journal on the field of Pharmacy and Pharmacology publishes critical reviews, perspectives, commentaries, and original research articles at the interface of disciplines itemized within pharmaceutical and related sciences, and takes great pride in keeping pace with latest research on how drug action/activity may be optimized using new technologies.
Why publish with us?
High Visibility: MJPS follows open access policy, thereby allowing the published articles to be accesses around the globe.
Promotion in Social Media: MJPS believes that serving the authors includes aggressively promoting their articles on social media platforms, and thereby ensuring them higher visibility.
Rigorous peer review: Every manuscript submitted undergoes a thorough and rigorous double-blind peer-review. This process eliminates subjective judgments and bias from the decision making process.
We welcome all types of articles related to Pharmaceutical Science. For submission assistance contact: i[email protected]. Please follow the Author Guidelines.
If you are not sure whether your work is suitable for this journal, please email us at i[email protected] or call us at +1-606-405–6566.
Published : 05th July 2024
Authors : Ezegbe Chekwube Andrew1,4,* Anikwe Celestine Chidera2, Uzondu Samuel WisdomofGod3,4, Okorie James Ekemezie1, Okafor Nnedimma Pauline1, Ezegbe Amarachi Grace5, Agu Kenechukwu Christian1, Okorafor Ezinne Chinemerem6, Aniagwu Ifunanya Sheila1
Citation : Andrew EC, et al. (2024). Formulation and in Vitro Evaluation of Liquisolid Compact of Celecoxib. Mathews J Pharma Sci. 8(2):31.
Published : 02nd July 2024
Authors : Vaibhav Adhao*, Jaya Ambhore, Anant Bhuskat, Dishali Talokar
Citation : Adhao V, et al. (2024). A Review on Analytical Methodologies for the Estimation of Anti-Retroviral Drugs Cabotegravir and Rilpivirine. Mathews J Pharma Sci. 8(1):30.
Published : 28th June 2024
Authors : Paolo Zanirato1,*, Silvia Businelli2
Citation : Zanirato P, et al. (2024). Synthesis and Antidiseas Evaluation of Some Bis-Heteroaryls (Thiophene or Selenophene) 1,2,3-triazoles C-trimethylsilylated. Mathews J Pharma Sci. 8(1):29.
Published : 13th June 2024
Authors : Amarachi Salome Chime1, Chekwube Andrew Ezegbe1,3,* Chidinma Judith Iyanyi1, Chukwunwike Godswill Onunkwo1, Amarachi Grace Ezegbe2, Nnedimma Pauline Okafor1
Citation : Chime AS, et al. (2024). Formulation, In-Vitro and In-Vivo Evaluation of Lamivudine-Loaded Solid Lipid Nanoparticles (SLNs). Mathews J Pharma Sci. 8(1):28.
Published : 18th May 2024
Authors : Ferruccio Trifirò*, Paolo Zanirato#
Citation : Trifirò F, et al. (2024). The Battle of the Physic and Chemistry against Pathogenic Microorganism. Mathews J Pharma Sci. 8(1):27.
Published : 01st April 2024
Author : Marjan Dzeparoski1,2,*
Citation : Dzeparoski M. (2024). Regulatory Update on eSubmissions in Balkans. Mathews J Pharma Sci. 8(1):26.